{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:20Z","timestamp":1791413300174,"version":"4.3.3"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.clinimag.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:34:27Z","timestamp":1555493667000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Tumor-induced osteomalacia \u2013 Current imaging modalities and a systematic approach for tumor localization"],"prefix":"10.1016","volume":"56","author":[{"given":"Sampanna Jung","family":"Rayamajhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifali","family":"Dumeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Remotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeuru","family":"Chikeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2019.04.007_bb0005","series-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2015"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0015","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-09-0597","article-title":"Fibroblast growth factor 23 and its role in phosphate homeostasis","volume":"162","author":"Ramon","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.clinimag.2019.04.007_bb0025","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/annonc\/10.suppl_2.S17","article-title":"Somatostatin receptors present knowledge and future directions","volume":"10","author":"Schonbrunn","year":"1999","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2019.04.007_bb0030","first-page":"847","article-title":"Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma","volume":"18","author":"Ferrari","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"issue":"9308","key":"10.1016\/j.clinimag.2019.04.007_bb0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","article-title":"The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels","volume":"86","author":"Ishii","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"10.1016\/j.clinimag.2019.04.007_bb0045","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.clinimag.2019.04.007_bb0050","first-page":"1922","article-title":"Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification","volume":"56","author":"Reubi","year":"1996","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinimag.2019.04.007_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","article-title":"68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT","volume":"64","author":"Breer","year":"2014","journal-title":"Bone"},{"issue":"26","key":"10.1016\/j.clinimag.2019.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clinimag.2019.04.007_bb0070","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jc.2013-3563","article-title":"Concordance between whole-body scintigraphy 111In-octreotide and 99mTc-sestamibi uptake in the detection of four tumor-induced osteomalacia cases","volume":"99","author":"Ferraz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clinimag.2019.04.007_bb0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/RLU.0b013e3182996293","article-title":"99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO)","volume":"38","author":"Jing","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1016\/j.clinimag.2019.04.007_bb0090","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/RLU.0b013e3182a20ded","article-title":"Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy","volume":"38","author":"Jin","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1016\/j.clinimag.2019.04.007_bb0095","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ejrad.2013.04.006","article-title":"Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan","volume":"82","author":"Jing","year":"2013","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.12426","article-title":"Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients","volume":"81","author":"Jadhav","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0105","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2967\/jnumed.111.088203","article-title":"Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors","volume":"52","author":"Grimes","year":"2011","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.clinimag.2019.04.007_bb0110","first-page":"652","article-title":"Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.clinimag.2019.04.007_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00402-008-0808-2","article-title":"Oncogenic osteomalacia: two case reports with surprisingly different outcomes","volume":"129","author":"Seijas","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"10.1016\/j.clinimag.2019.04.007_bb0120","first-page":"708","article-title":"An intrapatient comparison of 99mTc-EDDA\/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors","volume":"44","author":"Gabriel","year":"2003","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/ar.2014.5.0100","article-title":"Sinonasal phosphaturic mesenchymal tumor: case report and systematic review","volume":"5","author":"Deep","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.clinimag.2019.04.007_bb0130","doi-asserted-by":"crossref","first-page":"194123","DOI":"10.1155\/2014\/194123","article-title":"PET and PET\/CT with 68gallium-labeled somatostatin analogues in non GEP-NETs tumors","volume":"2014","author":"Sollini","year":"2014","journal-title":"TheScientificWorldJournal"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/RLU.0000000000000636","article-title":"Metastatic melanoma to the thyroid gland expressing somatostatin receptors-imaging with 68Ga-DOTANOC PET\/CT","volume":"40","author":"Jung","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","article-title":"Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography","volume":"22","author":"Hesse","year":"2007","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0145","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","article-title":"Tumor-induced hypophosphatemic rickets in an adolescent boy--clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue","volume":"95","author":"Haeusler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clinimag.2019.04.007_bb0150","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","author":"Zhang","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cen.12822","article-title":"Utility of Gallium-68 DOTANOC PET\/CT in the localization of tumour-induced osteomalacia","volume":"84","author":"Bhavani","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0160","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0165","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0170","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s00270-016-1350-1","article-title":"Ga-68 DOTATOC PET\/CT-guided biopsy and cryoablation with autoradiography of biopsy specimen for treatment of tumor-induced osteomalacia","volume":"39","author":"Maybody","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2019.04.007_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2967\/jnmt.116.177873","article-title":"177Lu-DOTATATE PRRT in recurrent skull-base phosphaturic mesenchymal tumor causing osteomalacia: a potential application of PRRT beyond neuroendocrine tumors","volume":"44","author":"Basu","year":"2016","journal-title":"J Nucl Med Technol"},{"issue":"7","key":"10.1016\/j.clinimag.2019.04.007_bb0180","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"ten Bokum","year":"1999","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17116\/patol201678119-24","article-title":"Somatostatin receptor expression in the ileal mucosa of patients with inflammatory bowel disease","volume":"78","author":"Tertychnyi","year":"2016","journal-title":"Arkh Patol"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0190","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.1780371017","article-title":"Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis","volume":"37","author":"Vanhagen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.clinimag.2019.04.007_bb0195","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1097\/RLU.0b013e31827a2325","article-title":"68Ga DOTATATE PET\/CT uptake in spinal lesions and MRI correlation on a patient with neuroendocrine tumor: potential pitfalls","volume":"38","author":"Klinaki","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.clinimag.2019.04.007_bb0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/RLU.0000000000000282","article-title":"(68)Ga DOTATATE uptake in vertebral hemangioma","volume":"39","author":"Brogsitter","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.remn.2014.03.005","article-title":"Dual false positive of (6)(8)Ga-DOTA-TATE PET\/CT scan in a patient with a history of pancreatic neuroendocrine tumor: a case report","volume":"34","author":"Demirci","year":"2015","journal-title":"Revista espanola de medicina nuclear e imagen molecular"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2967\/jnumed.112.114165","article-title":"Measured human dosimetry of 68Ga-DOTATATE","volume":"54","author":"Walker","year":"2013","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","article-title":"Reports of 17 Chinese patients with tumor-induced osteomalacia","volume":"35","author":"Yu","year":"2017","journal-title":"J Bone Miner Metab."},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0220","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/1346-8138.12602","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work","volume":"41","author":"Honda","year":"2014","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0972-3919.172344","article-title":"Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: our experience","volume":"31","author":"Jain","year":"2016","journal-title":"Indian J Nucl Med"},{"issue":"3 Suppl","key":"10.1016\/j.clinimag.2019.04.007_bb0235","doi-asserted-by":"crossref","first-page":"WS1","DOI":"10.2214\/AJR.07.7138","article-title":"Musculoskeletal pitfalls in 18F-FDG PET\/CT: pictorial review","volume":"193","author":"Costelloe","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.clinimag.2019.04.007_bb0240","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00003072-200107000-00007","article-title":"F-18 FDG uptake in a bone infarct: a case report","volume":"26","author":"Grigolon","year":"2001","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0245","first-page":"341","article-title":"Clinical and radiologic characteristics of craniomaxillofacial primary tumor induced osteomalacia: a retrospective analysis","volume":"51","author":"Wang","year":"2016","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0250","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12105-015-0668-3","article-title":"Phosphaturic mesenchymal tumor: 2 new oral cases and review of 53 cases in the head and neck","volume":"10","author":"Qari","year":"2016","journal-title":"Head Neck Pathol"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","article-title":"Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue","volume":"36","author":"Uramoto","year":"2009","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semnuclmed.2007.01.001","article-title":"Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography\/computed tomography (PET\/CT): accumulated data from four years of experience with PET\/CT","volume":"37","author":"Metser","year":"2007","journal-title":"Semin Nucl Med"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0265","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1097\/RLU.0b013e31826390cf","article-title":"Feasibility and incremental benefit of puffed-cheek 18F-FDG PET\/CT on oral cancer patients","volume":"38","author":"Chang","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cpet.2015.07.006","article-title":"Special techniques in PET\/computed tomography imaging for evaluation of head and neck cancer","volume":"11","author":"Kumar","year":"2016","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0275","first-page":"46","article-title":"Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET\/CT: a potential pitfall of standard-field imaging","volume":"19","author":"Kaneuchi","year":"2016","journal-title":"Hell J Nucl Med"},{"issue":"7","key":"10.1016\/j.clinimag.2019.04.007_bb0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12149-008-0153-0","article-title":"(18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET\/CT","volume":"22","author":"Shimamoto","year":"2008","journal-title":"Ann Nucl Med"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0285","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1590\/S0004-27302008000900016","article-title":"Oncogenic osteomalacia: localization of underlying peripheral tumor with 99mTc-sestamibi scintigraphy","volume":"52","author":"Biagini","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4158\/EP.12.1.35","article-title":"Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy","volume":"12","author":"Hodgson","year":"2006","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02985616","article-title":"Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia","volume":"18","author":"Kimizuka","year":"2004","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00003072-199602000-00008","article-title":"Comparison of Tc-99m MIBI and Tl-201 uptake in musculoskeletal lesions","volume":"21","author":"Adalet","year":"1996","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0305","first-page":"319","article-title":"Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP","volume":"33","author":"Caner","year":"1992","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0310","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00003072-199406000-00017","article-title":"Uptake of thallium-201 in brown tumor and bone fractures","volume":"19","author":"Adalet","year":"1994","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.clinimag.2019.04.007_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0972-3919.106702","article-title":"Oncogenic osteomalacia diagnosed by blood pool scintigraphy","volume":"26","author":"Palaniswamy","year":"2011","journal-title":"Indian J Nucl Med"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jor.2016.12.010","article-title":"Musculoskeletal oncogenic osteomalacia-an experience from a single centre in South India","volume":"14","author":"Satyaraddi","year":"2017","journal-title":"J Orthop"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0325","first-page":"173","article-title":"Bone scintigraphic patterns in patients of tumor induced osteomalacia. Indian journal of nuclear medicine","volume":"28","author":"Sood","year":"2013","journal-title":"IJNM"},{"issue":"11","key":"10.1016\/j.clinimag.2019.04.007_bb0330","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia","volume":"33","author":"Duet","year":"2008","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ncpendmet0639","article-title":"Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels","volume":"3","author":"Halperin","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0340","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clinimag.2019.04.007_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214766","article-title":"\u2018Rachitic rosary sign\u2019 and \u2018tie sign\u2019 of the sternum in tumour-induced osteomalacia","volume":"2016","author":"Chakraborty","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"13","key":"10.1016\/j.clinimag.2019.04.007_bb0350","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0355","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RHU.0b013e31827cd112","article-title":"Insufficiency fracture associated with oncogenic osteomalacia","volume":"19","author":"Niemeier","year":"2013","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0360","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-13-0581","article-title":"Six-year follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia","volume":"170","author":"Piemonte","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.clinimag.2019.04.007_bb0365","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4158\/EP.13.5.458","article-title":"Clinical and bone density outcomes of tumor-induced osteomalacia after treatment","volume":"13","author":"Umphrey","year":"2007","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0370","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ckj\/sfu004","article-title":"Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level","volume":"7","author":"Amblee","year":"2014","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0375","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2214\/ajr.167.2.8686600","article-title":"Oncogenic osteomalacia: lesion detection by MR skeletal survey","volume":"167","author":"Avila","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clinimag.2019.04.007_bb0380","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(99)00170-2","article-title":"Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia","volume":"25","author":"Fukumoto","year":"1999","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2463\/mrms.2011-0006","article-title":"Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia","volume":"12","author":"Nakanishi","year":"2013","journal-title":"Magn Reson Med Sci"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0390","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1148\/radiol.10090702","article-title":"Case 165: oncogenic osteomalacia","volume":"258","author":"Hendry","year":"2011","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0395","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/230949901402200231","article-title":"Oncogenic osteomalacia caused by phosphaturic mesenchymal tumours in the proximal and shaft of the tibia: a case report","volume":"22","author":"Pithankuakul","year":"2014","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"4","key":"10.1016\/j.clinimag.2019.04.007_bb0400","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3171\/2012.12.JNS12598","article-title":"Intracranial phosphaturic mesenchymal tumors: report of 2 cases","volume":"118","author":"Mathis","year":"2013","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.clinimag.2019.04.007_bb0405","doi-asserted-by":"crossref","first-page":"189 e1","DOI":"10.1016\/j.wneu.2015.02.030","article-title":"Osteomalacia-inducing tumors of the brain: a case report, review and a hypothesis","volume":"84","author":"Fathalla","year":"2015","journal-title":"World Neurosurg"},{"key":"10.1016\/j.clinimag.2019.04.007_bb0410","article-title":"Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors","volume":"2015","author":"Yavropoulou","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0415","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/jc.2013-3791","article-title":"Tumor(s) induced osteomalacia\u2014a curious case of double trouble","volume":"99","author":"Sahoo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clinimag.2019.04.007_bb0420","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1302\/0301-620X.92B7.24526","article-title":"Bilateral insufficiency fracture of the femoral head and neck in a case of oncogenic osteomalacia","volume":"92","author":"Chouhan","year":"2010","journal-title":"J Bone Joint Surg"},{"issue":"8","key":"10.1016\/j.clinimag.2019.04.007_bb0425","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2019.04.007_bb0430","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/jclinpath-2016-203893","article-title":"DOG1 expression in phosphaturic mesenchymal tumour","volume":"69","author":"Creytens","year":"2016","journal-title":"Journal of Clinical Pathology"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0435","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/pin.12295","article-title":"A case of phosphaturic mesenchymal tumor of the pelvis with vascular invasion","volume":"65","author":"Kimura","year":"2015","journal-title":"Pathol Int"},{"issue":"11","key":"10.1016\/j.clinimag.2019.04.007_bb0440","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","article-title":"Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis","volume":"44","author":"Uchihashi","year":"2013","journal-title":"Hum Pathol"},{"issue":"17","key":"10.1016\/j.clinimag.2019.04.007_bb0445","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006750","article-title":"Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report","volume":"96","author":"Qiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.clinimag.2019.04.007_bb0450","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1210\/jc.2012-1719","article-title":"Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation","volume":"97","author":"Tutton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.clinimag.2019.04.007_bb0455","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2013-4515","article-title":"Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients","volume":"99","author":"Jadhav","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clinimag.2019.04.007_bb0460","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc070347","article-title":"Radiofrequency ablation of a tumor causing oncogenic osteomalacia","volume":"357","author":"Hesse","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clinimag.2019.04.007_bb0465","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jbmr.3219","article-title":"Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia","volume":"32","author":"Tella","year":"2017","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"2","key":"10.1016\/j.clinimag.2019.04.007_bb0470","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/RLU.0000000000001461","article-title":"PET\/MR outperforms PET\/CT in suspected occult tumors","volume":"42","author":"Sekine","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.clinimag.2019.04.007_bb0475","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00261-015-0409-9","article-title":"Simultaneous (68)Ga-DOTA-TOC PET\/MRI with gadoxetate disodium in patients with neuroendocrine tumor","volume":"40","author":"Hope","year":"2015","journal-title":"Abdom Imaging"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707119300737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707119300737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:40:18Z","timestamp":1760269218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707119300737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":95,"alternative-id":["S0899707119300737"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2019.04.007","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-induced osteomalacia \u2013 Current imaging modalities and a systematic approach for tumor localization","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}